Login / Signup

Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.

Ian PangPeggy ChenGertrude V TrinhMats RembergerIgor Novitzky-BassoArmin GerbitzDennis Dong Hwan KimRajat KumarWilson LamArjun D LawJeffrey Howard LiptonAuro ViswabandyaIvan PasicJonas MattssonFotios V Michelis
Published in: European journal of haematology (2023)
Letermovir prophylaxis started at day +21 post-alloHCT reduced CMV reactivation, with no impact on posttransplant outcomes.
Keyphrases
  • low dose
  • bone marrow
  • stem cell transplantation
  • single cell
  • cell therapy
  • electronic health record
  • epstein barr virus
  • big data
  • stem cells
  • machine learning
  • skeletal muscle
  • data analysis
  • diffuse large b cell lymphoma